Browse everything: Tickers A–Z · Issuers · Comparisons · Tags
IMDX Stock — Insight Molecular Diagnostics Inc.
Insight Molecular Diagnostics Inc. (IMDX)
Updated October 16, 2026.
IMDX is a Stock. Total return is -98.1% over the past 10.8 years, 438.8 points behind SPY at 340.7%.
Insight Molecular Diagnostics Inc. is a precision diagnostics company that develops and commercializes laboratory-developed tests and clinical tests, with a focus on cancer monitoring, immunotherapy response prediction, and transplant rejection assessment. The company's pipeline includes blood-based tests such as DetermaCNI for early cancer progression detection and DetermaIO for predicting immunotherapy response, along with the GraftAssure family of tests for transplant monitoring. The company does not currently have an established distribution schedule.
IMDX performance versus SPY
Price and return data through 2026-10-16.
Total return is -98.1% over the past 10.8 years, 438.8 points behind SPY at 340.7%. Over the past year its total return — price change plus distributions reinvested — is -34.9%. Its deepest 1-year drawdown was 69.9%.
| Window | Total return | CAGR |
|---|---|---|
| 1M | -15.9% | — |
| 3M | -36.1% | — |
| 6M | -14.2% | — |
| YTD | -59.9% | — |
| 1Y | -34.9% | — |
| 2Y CAGR | — | -1.60% |
| 3Y CAGR | — | -0.40% |
| 5Y CAGR | — | -46.40% |
| 10Y CAGR | — | -28.20% |
| Since inception (10.8 years) | -98.1% | -30.90% |
IMDX key facts
- Asset type
- Stock
- Asset class
- Equity
- Inception date
- 12/30/2015
- Distribution frequency
- None
- Last close
- $3.01 (as of 2026-10-16)
- Market cap
- $98,500,095
- Average volume
- 181499.0
- Beta
- 1.805
- Payout ratio
- 0.0%
- EPS
- $-1.52
How Dividend Vision calculates yield and returns
Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.
Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology
Sources and review
Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.
Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.
IMDX risks and drawbacks
Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 69.9%.
Who may consider IMDX — and who may not
It is a weaker fit for investors who need monthly cash flow (IMDX does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.
More on IMDX
Frequently asked questions
Does IMDX pay monthly?
No. IMDX does not currently distribute.
When does IMDX pay a dividend?
IMDX does not currently distribute.
How has IMDX performed?
Total return is -98.1% over the past 10.8 years, 438.8 points behind SPY at 340.7%. Over the past year its total return — price change plus distributions reinvested — is -34.9%. Its deepest 1-year drawdown was 69.9%.
Tickers
Holdings as-of date unavailable.
| Ticker | Name | Weight |
|---|
See how this investment would fit into your portfolio.